Literature DB >> 27754570

Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation.

Ashwani K Singal1, Xiao Fang2, Mohamed Kaif1, Mohsen Hasanin3, Brendan M Mcguire1, Yong-Fang Kuo2, Russell H Wiesner4.   

Abstract

Patients with primary sclerosing cholangitis (PSC) have frequent episodes of cholangitis with potential for high mortality while waiting for liver transplantation. However, data on wait-list mortality specific to liver disease etiology are limited. Using United Network for Organ Sharing (UNOS) database (2002-2013), of 81 592 listed patients, 11 284 (13.8%) died while waiting for transplant. Primary biliary cirrhosis (PBC) patients (N = 3491) compared to PSC (N = 4905) differed with age (56 vs. 47 years), female gender (88% vs. 33%), black race (6% vs. 13%), and BMI (25 vs. 27), P < 0.0001 for all. A total of 993 (11.8%) patients died while waiting for the transplant list. Using competing risk analysis controlling for baseline recipient factors and accounting for receipt of liver transplantation (LT), PBC compared to patients with PSC had higher overall and 3-month wait-list mortality (21.6% vs. 12.7% and 5.0% vs. 2.9%, respectively, Gray's test P < 0.001), [1.25 (1.07-1.47)]. Repeat analysis including all etiologies showed higher wait-list mortality for PBC compared to most etiologies, except for patients listed for diagnosis of alcoholic liver disease (ALD) + hepatitis C virus (HCV). Patients with PBC have high mortality while waiting for liver transplantation. These novel findings suggest that patients with PBC listed for LT may be considered for model for end-stage disease (MELD) exception points.
© 2016 Steunstichting ESOT.

Entities:  

Keywords:  cirrhosis; transplantation; wait-list mortality

Mesh:

Year:  2016        PMID: 27754570     DOI: 10.1111/tri.12877

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  8 in total

1.  Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis.

Authors:  George Cholankeril; Humberto C Gonzalez; Sanjaya K Satapathy; Stevan A Gonzalez; Menghan Hu; Mohammad Ali Khan; Eric R Yoo; Andrew A Li; Donghee Kim; Satheesh Nair; Robert J Wong; Paul Y Kwo; Stephen A Harrison; Zobair M Younossi; Keith D Lindor; Aijaz Ahmed
Journal:  Clin Gastroenterol Hepatol       Date:  2018-02-08       Impact factor: 11.382

Review 2.  A brief review on prognostic models of primary biliary cholangitis.

Authors:  Sha Chen; Weijia Duan; Hong You; Jidong Jia
Journal:  Hepatol Int       Date:  2017-09-14       Impact factor: 6.047

Review 3.  Geoepidemiology and changing mortality in primary biliary cholangitis.

Authors:  Annarosa Floreani; Atsushi Tanaka; Christopher Bowlus; Merrill Eric Gershwin
Journal:  J Gastroenterol       Date:  2017-04-01       Impact factor: 7.527

4.  Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.

Authors:  Mehmet Sayiner; Maria Stepanova; Leyla De Avila; Pegah Golabi; Andrei Racila; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2019-08-27       Impact factor: 3.199

Review 5.  Emerging pharmacologic therapies for primary sclerosing cholangitis.

Authors:  Angela C Cheung; Konstantinos N Lazaridis; Nicholas F LaRusso; Gregory J Gores
Journal:  Curr Opin Gastroenterol       Date:  2017-05       Impact factor: 3.287

6.  Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates.

Authors:  Chung-Chou H Chang; Cindy L Bryce; Benjamin L Shneider; Jonathan G Yabes; Yi Ren; Gabriel L Zenarosa; Heather Tomko; Drew M Donnell; Robert H Squires; Mark S Roberts
Journal:  JAMA Pediatr       Date:  2018-11-01       Impact factor: 16.193

7.  Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades.

Authors:  Maren H Harms; Quisette P Janssen; Rene Adam; Christophe Duvoux; Darius Mirza; Ernest Hidalgo; Christopher Watson; Stephen J Wigmore; Massimo Pinzani; Helena Isoniemi; Johann Pratschke; Krzysztof Zieniewicz; Jurgen L Klempnauer; William Bennet; Vincent Karam; Henk R van Buuren; Bettina E Hansen; Herold J Metselaar
Journal:  Aliment Pharmacol Ther       Date:  2018-12-18       Impact factor: 8.171

8.  Mortality on the UNOS Waitlist for Patients with Autoimmune Liver Disease.

Authors:  Jaspreet S Suri; Christopher J Danford; Vilas Patwardhan; Alan Bonder
Journal:  J Clin Med       Date:  2020-01-23       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.